Shipment company

Frequency Exchange Subsidiary Announces First Nikkis Shipment Expected to Arrive in Canada in November

VANCOUVER, BC /ACCESSWIRE/October 6, 2022/ Frequency ExchangeCorp. (“Frequency Exchange” or the “Company”) (TSXV: FREQ) is pleased to announce that its wholly-owned subsidiary, FREmedica Technologies Inc. (“FREmedica”), will receive the first order of 5,000 personal wellness devices. being and performance, “NIKKI” on or about November 21, 2022, worth $1,250,000 in gross retail revenue. FREmedica has just confirmed that it has set the schedule for its next order of 25,000 NIKKIs with an expected delivery date at the end of the first quarter of 2023.

The results of our “Quality of Life/Proof of Concept” trial have set the stage to help millions of people struggling with issues related to sleep, pain and inflammation, lack of energy, stress and anxiety or a combination of all of the above.

NIKKI is a one-of-a-kind frequency transmitter that delivers frequencies into the body designed for well-being and performance enhancement.

“The most recent Proofof Concept trial confirms that NIKKI is a significant contributor to well-being and improved performance with demonstrated improvements in increased energy, reduced pain and inflammation , stress and anxiety relief and overall wellbeing. We are thrilled to see people signing up early to book their NIKKI because we trust them and believe they will have a great experience improving their health. and their performance. Says FREmedica President Nicole Sullivan.

Here are some of the results from the NIKKI 8-week trial:

A 26-year-old female subject with a long history of anxiety-related issues experienced less pain and stress, better sleep, and improved mood and energy.

After 2 months of wearing the device, a 46-year-old man solved his frontal headache problems, was able to sleep pain-free through the night, and gained vitality.

A 33-year-old woman with lifelong fatigue, insomnia, high blood pressure and anxiety experienced a significant reduction in symptoms and relief from her panic attacks.

The son of a study participant used the device to experience uninterrupted sleep, accelerated healing, and relief from severe burning neuropathy following a multiple leg fracture.

Learn more about and an overview of research findings and Dr. Connealy’s presentation on NIKKI.

About the company

Based in British Columbia, Canada, the company is focused on the development and commercialization of a frequency transmitter in markets around the world, offering specialized packages designed for health and well-being as well as the improvement performs. NIKKI is the fifth generation frequency transmitter launched by the company. It is the third wearable technology created by the company, initially to help customers with chronic Lyme disease. This wearable technology combined with frequencies is the result of years of development and experimentation with the latest bioenergetic technologies.

For more information please contact:

Frequency Exchange Corp.
Stephen Davis
CEO and director

FREmedica Technologies inc.
Nicole Sullivan
[email protected]

Caution Regarding Forward-Looking Information

Certain information contained herein constitutes “forward-looking information” under Canadian securities laws. Forward-looking information includes, but is not limited to, statements regarding when the Company’s common stock will trade on the Exchange. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “will” or variations of these words and phrases or statements that certain actions, events or results “will occur.” Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made and are subject to known and unknown risks, uncertainties and other factors that may cause actual results to differ. are materially different from those expressed or implied. by such forward-looking statements or forward-looking information. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Readers should not place undue reliance on forward-looking statements and forward-looking information. The Company will not update any forward-looking statements or forward-looking information incorporated by reference herein, except as required by applicable securities laws.

Additional information identifying the risks and uncertainties is contained in the documents filed by the Company with the Canadian securities authorities, which documents are available under the Company’s profile on SEDAR at

Neither the Bourse nor its Regulation Services Provider (as that term is defined in the policies of the Bourse) accepts responsibility for the adequacy or accuracy of this release.

THE SOURCE: Frequency Exchange Corp.